1. 1) Selkoe, D.J. (1994) Alzheimer’s disease: A central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438–447.
2. 2) Querfurth, H.W. and LaFerla, F.M. (2014) Alzheimer’s disease. N. Engl. J. Med. 362, 329–344.
3. 3) Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T. (1999) Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177.
4. 4) Orgogozo, J.M., Gilman, S., Dartigues, J.F., Laurent, B., Puel, M., Kirby, L.C. (2003) Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization. Neurology 61, 46–54.
5. 5) Nicoll, J.A., Wilkinson, D., Holmes, C., Steart, P., Markham, H. and Weller, R.O. (2003) Neuropathology of human Alzheimer’s disease after immunization with amyloid β peptide: A case report. Nat. Med. 9, 448–452.